Australia Home Infusion Therapy Market

Australia Home Infusion Therapy Market Overview:

The Australia home infusion therapy market size reached USD 1.27 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.39 Billion by 2033, exhibiting a growth rate (CAGR) of 6.51% during 2025-2033. The market is witnessing strong growth driven by the rising prevalence of chronic illnesses, increasing demand for at-home care, and advancements in infusion technology. The shift toward cost-effective outpatient care and improved patient convenience is accelerating market adoption. Growing healthcare expenditure and supportive insurance coverage are further boosting the Australia home infusion therapy market share.

Australia Home Infusion Therapy Market Trends:

Rising Chronic Disease Burden

Australia is experiencing a steady rise in chronic health conditions such as cancer, diabetes, congestive heart failure and autoimmune disorders. According to the data published by the Australian Institute of Health and Welfare, cancer cases in Australia are projected to rise significantly, estimating over 200,000 diagnoses by 2034. From 2000 to 2024, cases are expected to increase from 88,000 to 169,000, mainly due to population growth and aging. Despite improved survival rates cancer deaths are also anticipated to rise to 53,000. These diseases often require ongoing long-term treatment that can be administered intravenously. Home infusion therapy provides a practical alternative to hospital-based care by enabling patients to receive necessary treatments in the comfort of their homes. This approach not only improves quality of life but also reduces the risk of hospital-acquired infections and eases pressure on healthcare infrastructure. In particular, cancer patients needing chemotherapy, diabetic patients requiring insulin or hydration and those with immune deficiencies needing immunoglobulin therapy are increasingly turning to home-based solutions. The growing number of chronic disease patients combined with improved at-home care support and clinical monitoring is significantly contributing to the expansion of Australia’s home infusion therapy market.

Rising Geriatric Population

Australia’s aging population is playing a significant role in the rising demand for home infusion therapy. According to the data published by the Centre for Population, by 2064–65, nearly 25% of Australia’s population will be aged 65 and over, raising fiscal concerns. The Government’s reforms to the Aged Care Act aim for equity and sustainability. Birth rates, at record lows, are expected to remain so through 2024–25, while life expectancy gaps for Indigenous people persist. As life expectancy increases, so does the prevalence of age-related chronic conditions such as arthritis, cancer, cardiovascular diseases, and neurological disorders. Elderly patients often require regular infusions of medications like antibiotics, chemotherapy agents, or nutritional supplements, but frequent hospital visits can be physically and emotionally taxing. Home infusion offers a more convenient and comfortable alternative, enabling better treatment adherence and reducing hospital readmissions. Additionally, the elderly are more vulnerable to hospital-acquired infections, making home-based care a safer choice. Healthcare providers are increasingly tailoring infusion services to meet the unique needs of geriatric patients, supported by skilled nursing and remote monitoring. This demographic shift is expected to remain a major factor driving the Australia home infusion therapy market growth.

Australia Home Infusion Therapy Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on product and application.

Product Insights:

• Infusion Pumps
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

The report has provided a detailed breakup and analysis of the market based on the product. This includes infusion pumps (elastomeric, electromechanical, gravity, and others), intravenous sets, IV cannulas, and needleless connectors.

Application Insights:

• Anti-Infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes anti-infective, endocrinology (diabetes and others), hydration therapy (athletes and others), chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others.

Regional Insights:

• Australia Capital Territory & New South Wales
• Victoria & Tasmania
• Queensland
• Northern Territory & Southern Australia
• Western Australia

The report has also provided a comprehensive analysis of all the major regional markets, which include Australia Capital Territory & New South Wales, Victoria & Tasmania, Queensland, Northern Territory & Southern Australia, and Western Australia..

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Australia Home Infusion Therapy Market News:

• In March 2025, Baxter Healthcare and the Australian Government announced a $40 million investment to expand IV fluid manufacturing, which are essential for home infusion therapy, in Old Toongabbie, Sydney. The Labor Government will contribute $20 million, matched by Baxter, enhancing domestic production and reducing reliance on overseas supply. This project will create jobs and increase capacity significantly.
• In October 2024, BTC Health Limited announced that its drug infusion pumps, developed by BTC Specialty Health that can be used in home infusion settings, will be added to the Prescribed List of Medical Devices. This inclusion ensures automatic reimbursement from private health insurers, enhancing access to its innovative Elasto-Q and Rhythmic Evolution pumps for hospitals.

Australia Home Infusion Therapy Market Report Coverage:

Key Questions Answered in This Report:

• How has the Australia home infusion therapy market performed so far and how will it perform in the coming years?
• What is the breakup of the Australia home infusion therapy market on the basis of product?
• What is the breakup of the Australia home infusion therapy market on the basis of application?
• What is the breakup of the Australia home infusion therapy market on the basis of region?
• What are the various stages in the value chain of the Australia home infusion therapy market? 
• What are the key driving factors and challenges in the Australia home infusion therapy market?
• What is the structure of the Australia home infusion therapy market and who are the key players?
• What is the degree of competition in the Australia home infusion therapy market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Australia home infusion therapy market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Australia home infusion therapy market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Australia home infusion therapy industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.